Lu-28-179

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

Siramesine(Lu 28-179) HydroHClide 是一种选择性 sigma-2 受体激动剂，已被证明可触发 Y 细胞死亡并在体内表现出有效的抗癌活性。

Siramesine(Lu 28-179) hydrochloride is a selective sigma-2 receptor agonist, which has been shown to trigger cell death of Y cells and to exhibit a potent anticancer activity in vivo.

Siramesine hydrochloride displays the binding affinities: IC50 (sigma 1)=17 nM, IC50 (sigma 2)=0.12 nM, IC50 (5-HT1A)=21000 nM, IC50 (5-HT1A)=2000 nM, IC50 (D2)=800 nM, IC50 (alpha 1)=330 nM. Siramesine (0-50μM; 8 hours) hydrochloride induces cell death in various cell lines (HaCaT, Hsc-4, HeLa and MCF-7, neuroblastoma cell line SH-SY5Y and glioblastoma cell line U-87MG).Siramesine (0-40 μM; 2-48 hours) hydrochloride activates caspases in HaCaT and in U-87MG cells.

——

——

Autophagy

Sigma receptor

lysosome-destabilizing agent| σ2

Cancer

——

224177-60-0

491.04

C30H32ClFN2O

>98% (HPLC)

DMSO: 10 mM

Cl.FC1=CC=C(C=C1)N1C=C(CCCCN2CCC3(CC2)OCC2=CC=CC=C32)C2=CC=CC=C12

——

(-20℃)

With Ice Pack

≥ 2 years